Economic Evaluations of Cabazitaxel for Treatment of Post-docetaxel Metastatic Castration-resistant Prostate Cancer: Evidence from a Systematic Review
Nikinaz Ashrafi Shahmirzadi, Pardis Zaboli, Monireh Afzali, Bereket Molla Tigabu, Mirhamed Hajimiri, Arman Ajami & Nima Sepehri · Journal of Pharmaceutical Research International · 2019
Background and Objectives: Prostate cancer is an ever-increasing global incidence and has become the fifth leading cause of cancer-related mortality in men. A significant number of patients with prostate cancer develop metastatic castration-resistant prostate cancer (mCRPC). Ther...
Open access
Research Article
10.9734/jpri/2019/v31i630324